Alembic Pharmaceuticals Limited Rivaroxaban Export Data — India (DGFT 2022–2026)

Name: Alembic Pharmaceuticals Limited Rivaroxaban Export Records India — #10 Exporter, 38 Shipments, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rivaroxaban

India Pharmaceutical Trade Intelligence

$52.6M221 Suppliers115 CountriesHS 30049099

ExportsIndia → NETHERLANDS29.9%India → MALTA9.6%

ImportsGERMANY → India$34.1B CANADA → India$46.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Alembic Pharmaceuticals Limited — Rivaroxaban Exporter #10 | $1.3M Trade Value | TransData Nexus | TransData Nexus

Alembic Pharmaceuticals Limited — Rivaroxaban Exporter Profile

Indian Pharmaceutical Exporter · #10 for Rivaroxaban · $1.3M export value · DGFT Verified

Alembic Pharmaceuticals Limited is the #10 Indian exporter of Rivaroxaban with $1.3M in export value and 38 verified shipments. Alembic Pharmaceuticals Limited holds a 2.4% market share in Rivaroxaban exports across 7 countries. The company exports 37 pharmaceutical products worth $127.6M across 16 therapeutic categories.

Alembic Pharmaceuticals Limited — Rivaroxaban Export Profile: Buyers & Destinations

Alembic Pharmaceuticals Limited Rivaroxaban export treemap — buyers and destination countries | TransData Nexus

Where Does Alembic Pharmaceuticals Limited Export Rivaroxaban?

Country	Value	Shipments	Share
AUSTRALIA	$397.3K	17	51.1%
UNITED STATES	$119.3K	6	15.3%
NAMBIA	$114.9K	3	14.8%
GERMANY	$75.5K	4	9.7%
SOUTH AFRICA

Who Are the Top Buyers of Rivaroxaban from Alembic Pharmaceuticals Limited?

Buyer	Country	Value	Orders
APOTEX PTY LTD	AUSTRALIA	$157.2K	9
APOTEX PTY. LTD.	AUSTRALIA	$128.6K	5
ERONGOMED	NAMBIA	$114.9K	3
APOTEX PTY LTD.	AUSTRALIA	$100.0K	2
J KNIPPER COMPANY	UNITED STATES	$93.1K	4
LOXXESS PHARMA GMBH	GERMANY	$75.5K	4
RANBAXY PHARMACEUTICALS	SOUTH AFRICA	$48.7K	3
J. KNIPPER & COMPANY	UNITED STATES	$26.2K	2
STM HOLDINGS (PVT) LTD	ZIMBABWE	$21.3K	3
APOTEX PTY LTD.,	AUSTRALIA	$11.5K	1

Alembic Pharmaceuticals Limited supplies Rivaroxaban to 11 buyers globally. The largest buyer is APOTEX PTY LTD (AUSTRALIA), followed by APOTEX PTY. LTD. (AUSTRALIA) and ERONGOMED (NAMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Rivaroxaban Formulations Does Alembic Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
APO-RIVAROXABAN 20MG_2X14T ARROTEX	$100.0K	2
RIVAROXABAN AAA-PHARMA 2.5MG 20X10T DE	$62.7K	2
APO-RIVAROXABAN 15MG_2X14T ARROTEX	$50.0K	1
APO-RIVAROXABAN 20MG_2X14T ARROTEX_AU	$50.0K	1
APO RIVAROXABAN 20MG 2X14T ARROTEX	$50.0K	1
RIVAROXABAN TABLETS USP 2 5MG 62160 PACK X 60 S TABS	$47.2K	1
RIVAR 15MG(Rivaroxaban Tablets) 3X14 (3x	$46.9K	1
APO RIVAROXABAN 15MG 2X14T ARROTEX	$43.8K	1
RIVAR 20MG (Rivaroxaban Tablets) 2X14 (2	$36.5K	1
RIVAR 10MG(Rivaroxaban Tablets) 3X10 (3x	$31.6K	1

Alembic Pharmaceuticals Limited exports 35 distinct Rivaroxaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is APO-RIVAROXABAN 20MG_2X14T ARROTEX with 2 shipments worth $100.0K.

How Does Alembic Pharmaceuticals Limited Compare to Nearest Rivaroxaban Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	TORRENT PHARMACEUTICALS LTD	$2.1M	59	5	$35.8K
9	INTAS PHARMACEUTICALS LIMITED	$1.6M	165	13	$9.9K
10	ALEMBIC PHARMACEUTICALS LIMITED ★	$1.3M	38	7	$33.5K
11	LUPIN LIMITED	$1.2M	28	3	$44.2K
4	CARITAS HEALTHCARE PRIVATE LIMITED	$1.1M	22	1	$50.0K

Alembic Pharmaceuticals Limited ranks #10 among 221 Indian Rivaroxaban exporters. Average shipment value of $33.5K compared to the market average of $166.0K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Rivaroxaban Exports?

Port	Shipments	% Share
SAHAR AIR	1,144	21.3%
DELHI AIR CARGO ACC (INDEL4)	985	18.4%
DELHI AIR	659	12.3%
SAHAR AIR CARGO ACC (INBOM4)	635	11.8%
Bombay Air	197	3.7%
NHAVA SHEVA SEA (INNSA1)	164	3.1%
Delhi Air	133	2.5%
HYDERABAD AIR	110	2.1%

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Rivaroxaban Exports

Alembic's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The recent escalation of conflicts in the Middle East, particularly the Israel-Iran tensions, has led to heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor. Major carriers have altered their routes, opting for the longer passage around the Cape of Good Hope, resulting in extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes. (livemint.com) For Alembic, which exports to European markets, these disruptions could lead to delays and elevated shipping costs, impacting supply chain efficiency and profitability.

Conversely, the ongoing U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters. The United States' efforts to diversify its supply chain away from China have opened avenues for companies like Alembic to strengthen their presence in the U.S. market. The company's proactive approach is evident in its acquisition of Utility Therapeutics Ltd., facilitating entry into the U.S. branded drug segment. (pharma.economictimes.indiatimes.com) However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for Alembic's operations in Europe. Ensuring adherence to serialization and traceability requirements is essential to maintain market access and avoid regulatory penalties.

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Alembic Pharmaceuticals has consistently demonstrated adherence to stringent regulatory standards set by agencies such as the USFDA, WHO, and EU GMP. The company's manufacturing facilities have received approvals from various international regulatory bodies, underscoring its commitment to quality and compliance. (en.wikipedia.org) Notably, Alembic's proactive approach to addressing regulatory challenges is evident in its successful resolution of the nitrosamine issue affecting products like Duloxetine. By stabilizing the product and obtaining necessary dossier approvals, the company has reinforced its dedication to product safety and regulatory compliance. (alembiclimited.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Alembic Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 38 individual customs records matching Alembic Pharmaceuticals Limited exporting Rivaroxaban, covering 35 formulations to 7 countries via 11 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 497+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rivaroxaban

Rivaroxaban

Alembic Pharmaceuticals Limited — Rivaroxaban Exporter Profile

Alembic Pharmaceuticals Limited — Rivaroxaban Export Profile: Buyers & Destinations

Where Does Alembic Pharmaceuticals Limited Export Rivaroxaban?

Who Are the Top Buyers of Rivaroxaban from Alembic Pharmaceuticals Limited?

What Is India's Total Rivaroxaban Export Value and How Much Does Alembic Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Alembic Pharmaceuticals Limited's Rivaroxaban Exports?

How Does Alembic Pharmaceuticals Limited Compare to Other Indian Rivaroxaban Exporters?

What Rivaroxaban Formulations Does Alembic Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Rivaroxaban to Key Markets

Australia — TGA

United States — FDA

How Does Alembic Pharmaceuticals Limited Compare to Nearest Rivaroxaban Exporters?

Which Indian Ports Ship Rivaroxaban Exports?

What Other Cardiovascular Products Does Alembic Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Alembic Pharmaceuticals Limited's Rivaroxaban Exports

Alembic Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Alembic Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rivaroxaban Export Data from Alembic Pharmaceuticals Limited

Rivaroxaban Stats

Company Overview

Top Products by Alembic Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source